About BioTek
BioTek is a company based in Winooski (United States) founded in 1993 was acquired by Agilent in July 2019. BioTek offers products and services including Chromatography Systems, Mass Spectrometry, and Microplate Instrumentation. BioTek operates in a competitive market with competitors including Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
- Headquarter Winooski, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sr Biotek, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioTek
BioTek is a publicly listed company on the KRX with ticker symbol 270210 in South Korea, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioTek
BioTek offers a comprehensive portfolio of products and services, including Chromatography Systems, Mass Spectrometry, and Microplate Instrumentation.
Equipment for separating chemical mixtures in laboratories.
Tools for identifying molecules in research applications.
Devices for cell analysis and high-throughput screening.
Funding Insights of BioTek
Detailed funding history for BioTek
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BioTek
BioTek has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Agilent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified instruments are developed for scientific and laboratory management.
|
Locked | Locked | Locked |
Investor details for BioTek
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioTek
Investment portfolio details for BioTek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioTek
Detailed financials for BioTek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotek Comparisons
Peer comparison for BioTek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioTek
BioTek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Lucid Scientific, Kiyatec, CytoTronics and Saguaro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
|
| Locked | Locked | Locked |
3D cell culture products are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Metastatic cancer properties are targeted by Remedy Plan's containment therapy.
|
Detailed competitors of BioTek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotek
Complete news archive for BioTek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioTek
BioTek was founded in 1993.
BioTek is headquartered in Winooski, United States. It is registered at Winooski, Vermont, United States.
Briar Alpert is the current CEO of BioTek.
Annual revenue of BioTek is $7.04K as on Mar 31, 2023.
Founded in 1993 and headquartered in Winooski, United States, BioTek focuses on the life sciences sector. Imaging systems, detection instruments, liquid handling tools, robotics, and software for microplate-based in vitro assays are developed and manufactured. Products include automated cell imagers like Lionheart FX, multi-mode readers such as Cytation, washers, dispensers, stackers, and Gen5 software. Applications span cellular and cell-free assays in research settings.
BioTek's top competitors include CytoTronics, Kiyatec and Remedy Plan.
BioTek offers Chromatography Systems, Mass Spectrometry, and Microplate Instrumentation.
Yes, BioTek is publicly traded on KRX under the ticker symbol 270210.
BioTek has 1 investor. Key investors include Agilent.
The ticker symbol of BioTek is 270210 on KRX.